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In recent years cancer stem cells (CSCs) have been hypothesized to comprise only a minor
subpopulation in solid tumors that drives tumor initiation, progression, and metastasis;
the so-called “cancer stem cell hypothesis.” While a seemingly trivial statement about
numbers, much is put at stake. If true, the conclusions of many studies of cancer cell pop-
ulations could be challenged, as the bulk assay methods upon which they depend have,
by, and large, taken for granted the notion that a “typical” cell of the population possesses
the attributes of a cell capable of perpetuating the cancer, i.e., a CSC. In support of the
CSC hypothesis, populations enriched for so-called “tumor-initiating” cells have demon-
strated a corresponding increase in tumorigenicity as measured by dilution assay, although
estimates have varied widely as to what the fractional contribution of tumor-initiating cells
is in any given population. Some have taken this variability to suggest the CSC fraction
may be nearly 100% after all, countering the CSC hypothesis, and that there are simply
assay-dependent error rates in our ability to “reconfirm” CSC status at the cell level. To
explore this controversy more quantitatively, we developed a simple cellular automaton
model of CSC-driven tumor growth dynamics. Assuming CSC and non-stem cancer cells
(CC) subpopulations coexist to some degree, we evaluated the impact of an environmen-
tally dependent CSC symmetric division probability and a CC proliferation capacity on tumor
progression and morphology. Our model predicts, as expected, that the frequency of CSC
divisions that are symmetric highly influences the frequency of CSCs in the population, but
goes on to predict the two frequencies can be widely divergent, and that spatial constraints
will tend to increase the CSC fraction over time. Further, tumor progression times show a
marked dependence on both the frequency of CSC divisions that are symmetric and on the
proliferation capacities of CC.Together, these findings can explain, within the CSC hypoth-
esis, the widely varying measures of stem cell fractions observed. In particular, although
the CSC fraction is influenced by the (environmentally modifiable) CSC symmetric division
probability, with the former converging to unity as the latter nears 100%, the CSC fraction
becomes quite small even for symmetric division probabilities modestly lower than 100%.
In the latter case, the tumor exhibits a clustered morphology and the CSC fraction steadily
increases with time; more so on both counts when the death rate of CCs is higher. Such
variations in CSC fraction and morphology are not only consistent with the CSC hypothe-
sis, but lend support to it as one expected byproduct of the dynamical interactions that are
predicted to take place among a relatively small CSC population, its CC counterpart, and
the host compartment over time.
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INTRODUCTION
Normal tissues undergo constant turnover, with cells dying due to
age, injury, or shedding, and being replaced by new healthy cells.
Homeostasis is accomplished by a potent subpopulation of stem
cells. In recent years, a potent subpopulation of stemlike cells has
also been proposed to exist as a minority population in cancers.
First in leukemia and later in solid tumors, distinct cell populations
were isolated that were either capable or not capable of initiating
and sustaining, and re-initiating tumor growth (Furth and Kahn,
1937; Al-Hajj et al., 2003; Singh et al., 2003; Visvader and Linde-
man, 2008; Vlashi et al., 2009). The picture to emerge – that of
a potent cancer stem cell (CSC) that initiates and progresses the
tumor, with the bulk of the growing tumor being composed of
replication-limited cancer cells (CCs) – stands in marked contrast
to the long-established paradigm that cancer cells typically are
long-lived, escape cell death, and have limitless replicative poten-
tial (Hanahan and Weinberg, 2000, 2011), and argues against one
recent study (Quintana et al., 2008), which has been interpreted
to suggest we may simply be “under-assaying” the preponderant
stem cell population (Baker, 2008). Summing up this alternative
paradigm is the CSC hypothesis, perhaps better described as a
cancer “non-stem cell” hypothesis, which posits that in fact only a
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few cells in the tumor population exhibit the immortal, stemlike
trait. Confusion sometimes accompanying the CSC terminology
regards the cell of origin of the disease. While the term “CSC”
clearly suggests these cells possess stemlike qualities, this should
not be taken to suggest they originate from normal stem cells.
Indeed, the literature is split on the matter of origin (Haeno et al.,
2009; Rahman et al., 2009; Shibata and Shen, 2013), with debates
occurring occasionally even within the same tumor type, as in the
case in glioblastoma (Stiles and Rowitch, 2008; Hambardzumyan
et al., 2011).
Populations enriched for stemness can be isolated using dif-
ferent surface markers. The number of cells from such enriched
populations that is necessary to form tumors gives an indication
of the fraction of cells that are CSCs in the primary tumor. We cal-
culated these ratios from data reported in the literature (Visvader
and Lindeman, 2008) (Table 1), and found these tend to support
numerous other reports that CSCs are indeed a rare population
within a tumor (Reya et al., 2001; Pardal et al., 2003). In addition
to identification of CSCs through surface proteins in vitro and
in vivo mouse xenograft transplantation assays, novel approaches
emerge that trace tumor hierarchy and help estimate CSC kinetics
and frequency in spontaneous tumors or orthotropic models. One
approach to monitor the division kinetics of stem and progenitor
cells in normal epithelial tissues, skin papilloma, and invasive squa-
mous cell carcinoma during unperturbed growth emerged from
clonal analysis using genetic lineage tracing in mice (Driessens
et al., 2012). Gao et al. (2013) used an integrated experimen-
tal and cellular Potts model approach to simulate glioblastoma
population growth and response to irradiation, which identified
the (a)symmetric division kinetics of glioblastoma stem cells nec-
essary to reproduce the observed ratio of 2–3% of such cells.
Table 1 | Cancer stem cells in solid tumors.









Breast 11–35 200 1.1×10−3
ND 2000
3–10 500
Brain 19–29 100 3.3×10−4
6–21 100
Colon 1.8–25 200 5.4×10−4
0.7–6 3000
0.03–38 200
Head and neck 0.1–42 5000 4.2×10−5
Pancreas 0.2–0.8 100 3.5×10−5
1–3 500
Lung 0.32–22 10,000 1.1×10−4
Liver 0.03–6 5000 6×10−6
Adapted from Visvader and Lindeman (2008).
Another integrated approach of single-molecule genomic data,
spatial agent-based modeling, and statistical inference was recently
introduced to derive tumor ancestral trees in patient-specific
colorectal cancer samples that lead to the observation of a CSC
fraction of 0.5–4% (Sottoriva et al., 2013).
One mechanism responsible for establishing the CSC fraction
within a tumor is the relative frequency with which CSCs either
create another CSC (by symmetric division) or a non-CSCs (by
asymmetric division) (Caussinus and Hirth, 2007; Dingli et al.,
2007b). Mechanisms known to directly affect the symmetric divi-
sion probability, in turn, include availability of certain host growth
factors such as EGF, and growth-factor-rich niches, which can skew
division modes in favor of symmetric production of CSC up to
85% (Lathia et al., 2011). Another mechanism responsible for the
observed CSC fraction in tumors is factor-independent, and may
be traced to the aggregate population-level action of cell prolif-
eration, migration, and apoptosis; a process we have previously
described as “self-metastatic” growth (Norton, 2005; Enderling
et al., 2009b). Underlying this notion, each CSC can only form
a cluster of limited size (Prehn, 1991), until such time as it can
opportunistically migrate out of its current cluster to seed a new
cluster nearby.
To show how these influences comprising the CSC hypothesis
can give rise to realistic tumor growth dynamics and morpholo-
gies, we used an agent-based cellular automaton model of tumor
population dynamics that considers the kinetics and interactions
of CSC and CCs. Consistent with observation, we show that host-
dependent variations in (a)symmetric CSC division ratios can
yield tumors with substantially different CSC pool sizes and over-
all tumor morphologies. Furthermore, we show, by virtue of the
properties of CSCs and their progeny, that the CSC fraction in a
tumor grows over time, regardless of how quickly the tumor as a
whole grows. As will be argued, these findings can explain the large
variation in CSC fractions within and among tumors reported
throughout the literature (Reya et al., 2001; Visvader and Linde-
man, 2008), and offer a new paradigm for cancer development
within the CSC hypothesis.
MATERIALS AND METHODS
We use an agent-based cellular automaton model to describe the
behavior of individual tumor cells dependent on intrinsic mech-
anisms of proliferation, migration, and cell death. By tracking
the fate of multiple cells over time we simulated the emergence
of interacting tumor cell populations that compete for the same
environment (see Deutsch and Dormann, 2005 for an overview
of similar approaches). Such theoretical frameworks are increas-
ingly utilized to investigate different aspects of the CSC hypothesis
(Deasy et al., 2003; Dingli and Michor, 2006; Ganguly and Puri,
2006; Ashkenazi et al., 2007; Bankhead et al., 2007; Dingli et al.,
2007b; Michor, 2008; Piotrowska et al., 2008; Galle et al., 2009;
Glauche et al., 2009; Johnston et al., 2010; Sottoriva et al., 2010).
Ganguly and Puri (2006) developed a compartment model of
normal stem cells, early and late progenitors, and mature cells
in the neural lineage as well as their abnormal counterparts.
Through numerical simulation of physiologic homeostasis in their
deterministic ordinary differential equation model, the authors
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explored the impact of mutations in the stem cell and early
progenitor populations. As stem cells have a larger proliferation
potential, they found that mutations in stem cells lead to a larger
tumor population growth rate. Considering normal and abnor-
mal stem and differentiated cell populations of the hematopoietic
system, Dingli and Michor (2006) showed in a simple ordinary
differential equation model that successful therapy must eradicate
the CSCs. Therapy that targets mature CCs or partially induces
differentiation of stem cells is unable to provide tumor control.
Recent mathematical investigations into the fraction of CSCs in
solid tumors either assumed a fixed proportion of these cells and
explored the cell kinetic parameters in a hierarchical ordinary
differential equation model that lead to proportional stability in
the cancer lineage (Molina-Peña and Álvarez, 2012), or simulate
the exponential phase of tumor growth and observe a constant
minor proportion of CSCs in an ordinary differential equation
model (Johnston et al., 2010) or in a cellular automaton approach
(Morton et al., 2011). Recently, Hillen et al. (2013) used reaction-
birth processes and developed a mean-field integro-differential
equation system to describe spatio-temporal tumor growth under
the CSC hypothesis. Analyzing the simplified ordinary differen-
tial equation system of their model, the authors were able to
show that tumor growth accelerates with increased cell death and
that the tumor population monotonically evolves to a pure CSC
state. Using a partial differential equation approach to simulate the
spatio-temporal dynamics of cell lineage in solid tumors, Youssef-
pour et al. (2012) were able to observe complex pattering with
CSCs being predominantly located in individual clusters at the
outer rim of the total population in response to a variety of cel-
lular feedback mechanisms and oxygen tension. Similar to our
agent-based model investigations into CSC-driven solid tumor
growth (Enderling et al., 2009a,b), Sottoriva et al. (2010) recently
developed a hybrid cellular automaton model to study tumor mor-
phology and phenotypical heterogeneity in the classical cancer
model where all cells can be considered CSCs, and in the CSC
model with populations heterogeneous for proliferation poten-
tial. In addition to increasing invasiveness with decreased CSC
fraction, the model revealed a constant CSC fraction during expo-
nential growth phases. While Sottoriva and co-workers assumed
intratumoral proliferation through pushing adjacent cells toward
the tumor periphery, we set out to explore tumor growth dynamics
and morphology evolution when proliferation is restricted to the
tumor outer rim as a result of competition for space in the tumor
interior (Brú et al., 2003; Drasdo and Höhme, 2005; Galle et al.,
2009). We will explore global cancer features in an agent-based
model as a function of environmentally modulated CSC symmet-
ric division rates as well as the proliferative potential of the CC
population, and discuss evolution of the tumor population and
CSC fraction during local tissue invasion.
A detailed description of the agent-based model assumptions
and biological motivation can be found elsewhere (Enderling et al.,
2009a,b; Enderling and Hahnfeldt, 2011). To summarize, at time
t = 0, we initiate a single cell in the center of our computational
lattice (domain) of 10 mm× 10 mm, subdivided into 1000× 1000
equal-sized lattice points of (10µm)2 that can hold at the most
one cell at any time. By simulating (a)symmetric cell proliferation,
migration, and cell death kinetics at discrete time intervals ∆t, a
population of cancer cells emerges, which we track until it reaches
100,000 cells. In this procedure, we assume CCs are able to prolif-
erate a certain number of times, ρmax, before inevitable cell death
and ultimate removal from the simulation. For CSCs, we assume
ρmax=∞. CSCs divide symmetrically with fixed probability ps,
and asymmetrically with probability 1− ps. Cells need to mature
through the cell cycle before division can occur, which takes a
cell-type-dependent time τ. With available adjacent space, a cell
can migrate with rate µ. Otherwise, the cell is forced into qui-
escence until space becomes available. With probability α, CCs
undergo spontaneous cell death and vacate the space they occupy.
CSCs are assumed to be immortal (α= 0). A flowchart of the
simulation process and decisions at the cell level is shown in
Figure 1.
RESULTS
SYMMETRIC STEM CELL DIVISION PROBABILITY PS AND TUMOR
GROWTH
Tumor growth is simulated and analyzed for various stem cell
division probabilities ps= (0.1, 0.25, 0.5, 0.75, 0.99) and various
progeny proliferation capacities ρmax= (10, 15, 20), which are in
line with reported progeny division potentials for different tissues
(Bernard et al., 2003; Ashkenazi et al., 2007). As previously shown,
tumors in which CCs have high values of ρmax grow significantly
slower than tumors with CCs with limited proliferation capac-
ity (low ρmax) (Enderling et al., 2009a). With proliferation being
dependent on available space, tumor growth is restricted to cells on
the outer rim of cell clusters, which is frequently observed in vitro
and in vivo (Brú et al., 2003; Drasdo and Höhme, 2005; Galle et al.,
2009). CSCs become “trapped” in the tumor core and are forced
into quiescence until space becomes available again – either after
adjacent CCs have migrated away or died. These kinetics have
been shown to be inversely dependent on CC proliferation capac-
ity and death rate (Enderling and Hahnfeldt, 2011; Morton et al.,
2011).
We now relate the effect of symmetric CSC division prob-
ability ps on tumor growth. A high symmetric CSC division
probability (ps= 0.99; i.e., 99%) is found to yield tumors with
a very large CSC population (93%). Tumors of 100,000 cells
are formed within 49 days regardless of the CC proliferation
capacity. Lower symmetric stem cell division probabilities of
ps= 75% and ps= 50% result in both a smaller stem cell com-
partment (15.5 and 5.4%, respectively) and more progeny CCs
that act to encapsulate and slow the expansion of the available
CSCs, prolonging tumor growth to 56 and 72 days, respectively,
for ρmax= 10, and 56(63) and 226(586) days for ρmax= 15(20)
(Figure 2). CSC fractions are reduced further to 1.8 and 0.5% for
ps= 25% and 10%, respectively. In the latter case, tumor growth
takes as long as 3351(1451 and 282) days for ρmax= 20(15 and 10),
respectively.
The intrinsic and/or extrinsic mechanisms that regulate
(a)symmetric CSC division are not yet understood, but modeling
predicts that if the symmetric division probability is even mod-
estly less than 100% – which it must be given the observed cell
fate heterogeneity within a tumor – the CSC compartment rapidly
becomes a minor subpopulation within tumors (Figure 2) and
remains that way at least for a long while.
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FIGURE 1 | Flowchart of the simulation process and decisions on the cell level. CSC, Cancer stem cell; CC, non-stem cancer cell; ρ, proliferation capacity.
SYMMETRIC STEM CELL DIVISION PROBABILITY PS AND TUMOR
MORPHOLOGY
Within the CSC hypothesis tumor growth follows an interesting
pattern. CSCs can only form tumor clusters of limited size before
self-inhibition (Prehn, 1991). Tumor growth and progression is
achieved by shedding of CSCs from the tumor clusters and seeding
of new clusters nearby – a process termed self-metastatic growth
(Norton, 2005; Enderling et al., 2009b, 2010). Figure 3 shows the
spatio-temporal evolution of tumor morphology for various sym-
metric stem cell division probabilities and thus various stem cell
pool sizes within the tumors. As expected, and in line with the lit-
erature, homogeneous tumor populations consisting of only stem
cells (or a sufficiently large stem cell compartment) grow in a radi-
ally symmetric manner (Drasdo and Höhme, 2005; Enderling and
Hahnfeldt, 2011). Small symmetric stem cell division probabilities,
by contrast, result in CSCs being scattered throughout the tumors
through self-metastatic progression. As this continues, the tumor
clusters become bigger and intermingle, giving rise to clusters of
stem cells, likened to stem cell niches in normal tissues (Figure 3).
Tumor morphology is often used as a measure of tumor inva-
siveness. A compact, circular morphology is associated with less
invasiveness than an irregular, fingering morphology (Anderson,
2005; Anderson et al., 2006). To assess this, we measured tumor
compactness, or “circularity,” i.e., tumor density as a function
of radial distance from the tumor’s center of mass, for various
symmetric division probabilities ps (Figure 4). It is observed that
tumor morphology can be described by three distinct regions: (i)
a non-linear (saturated) region without significant changes over
time in the bulk tumor core close to the center of mass, (ii) a deter-
ministic region dominated by cell proliferation and diffusion, and
(iii) a highly fluctuating outer rim zone distant from the center
of mass with a low cell density that is dominated by random cell
migration (Hatzikirou et al., 2010). Tumors comprised primar-
ily of CSCs form a very dense, saturated tumor without a largely
fluctuating outer rim, as the effect of random migration at the
tumor boundary is nullified by continuous stem cell proliferation.
A smaller dense core and a larger deterministic and highly fluctu-
ating self-metastatic region characterize tumors with lower stem
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FIGURE 2 |Tumor development time and stem cell fractions depend
on progeny proliferation capacity ρmax and stem cell symmetric
division probability ps.The time until the tumor reaches 100,000 cells
(lines) decreases with increasing ps. For small ps (ps = 10%, 25%), the
stem cell fraction (columns) increases with increasing progeny
proliferation capacity ρ, but for larger ps the trend reverses. For ps =50%
there is a U -shape dependence on ρmax. For ps ≤75%, the stem cell
fraction is substantially less than the symmetric division probability ps. For
ps =50%, the average stem cell fraction in a 100,000-cell tumor is less
than 5% for each ρmax.
FIGURE 3 | Representative tumor morphologies for symmetric division probabilities ps = 10, 25, 50, 75, and 99% (rows), and for ρmax =10, 15, and 20
(panels left to right). All tumors grown to 100,000 cells.
cell fractions. Of note, in tumors with larger progeny prolifera-
tion capacities [ρmax= (15, 20)] there is a non-linear, U -shaped
dependence of tumor compactness on stem cell fraction. Smaller
and larger symmetric stem cell division probabilities ps yield a
more compact tumor morphology, whereas a symmetric division
probability of ps= 50% features the most invasive morphology
with the smallest dense core and the most widespread proliferative
and motile regions.
STEM CELL FRACTION AS A FUNCTION OF TIME
Beyond the dependence of tumor growth dynamics on cell kinetic
parameters, environmental constraints may also modulate tumor
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FIGURE 4 | Dependence of tumor morphology on stem cell
symmetric division probability and proliferation capacity
ρmax =10 (A), 15 (B), 20 (C). Plotted against radial distance from the
center of mass of the tumor is tumor “circularity” (the percent
occupancy of lattice points by tumor cells at the given radial distance),
a measure of the tumor’s irregularity/invasiveness. For ρmax = (15, 20),
the dependence of circularity on ps is U -shaped. All tumors grown to
100,000 cells.
progression and architecture. Tumors growing in vivo compete
with the environment not only for oxygen and nutrients (which
are not very limiting in the early phases of tumor growth), but
also for space to grow and proliferate. Different host tissues, such as
epithelial membranes or dense muscle structures (Figure 5) retard
tumor progression. Single cells will eventually be able to infiltrate
the tissue and thus form a path for local invasion. We introduce
a “host tissue” in our computational domain by discretizing a
hematoxylin-eosin (H&E)-stained tissue sample of a murine Lewis
lung carcinoma – mouse muscle tissue interface. For the purpose of
our study,we did not model anatomically precise cell structures but
limited the tissue structure to average local cell densities (Figure 5).
We introduce a single CSC in the top right corner of the domain
and simulate tumor growth with either ps= 100%, representing a
pure CSC tumor, or ps= 10%. Tumors consisting solely of stem
cells quickly populate the empty space representative of tissue with
low density, and with a reduced growth rate into the dense mus-
cle structure and less dense tissue areas beyond. Heterogeneous
tumor populations (ps= 10%) populate the less dense tissue via
formation of self-metastases, as previously described (Enderling
et al., 2009b), and the denser structures with a further reduced
growth rate. Snapshots of the spatial distribution of 13,000 tumor
cells for both tumors (ps= 100 and 10%) reveal no difference in
morphology (Figure 5). The circular and self-metastatic tumor
morphologies evident in the respective tumors without host con-
straints (c.f., Figure 3) are no longer present. Instead, in vivo
tumor morphology is dictated by host tissue architecture. What
is seen, however, is a significant difference in tumor growth and
growth rate history. While stem cell tumors fill the available space
and form a mass of 13,000 cells within about 100 days, the het-
erogeneous tumor takes 20 times longer (72 months) to reach a
comparable size and morphology (Figure 5). In the presented sam-
ple simulation, the empty space to the right of the muscle tissue is
populated by the heterogeneous tumor within 12 months, but the
invasion of the muscle structure takes significantly longer (another
60 months), during which time the overall CSC fraction goes from
60/9500 (0.6%) to 2050/13,000 (15.8%). Simulation snapshots
at different time points clarify the heterogeneous tumor growth
dynamics and stem cell fraction evolution (Figure 5). When the
tumor population reaches the dense muscle structure, single cells
try to invade the narrow gaps between muscle cells. As more than
99% of the tumor is comprised of CCs at the time invasion com-
mences, the infiltrating and invading cells can only form small
clusters of cells that eventually die out, blocking invasion routes,
and inhibiting tumor invasion. Only the eventual opportunistic
infiltration of a CSC results in successful metastatic seeding of
these interstices within the muscle architecture. Figure 5 shows
how these spaces fill with microscopic cancer nodules that over
time disappear again, awaiting the chance entry of a stem cell.
The necessity of rare CSCs, which are predominantly migration-
and proliferation-inhibited by their own progeny as well as by
host tissue, to infiltrate and invade host tissue structures can, at
least in part, explain the frequently observed poor efficiency of
metastization (Luzzi et al., 1998; Wyckoff et al., 2000; Dingli et al.,
2007a). As remarked, the overall CSC frequency increases over
time as dying CCs get opportunistically replaced by CSCs. Such
a time-dependent tumor stem cell fraction offers one plausible
explanation for the wide spread of stem cell fractions reported in
the literature even for tumors of the same tissue of origin (Quin-
tana et al., 2008; Visvader and Lindeman, 2008) (c.f., Table 1).
These results are amplified when the CC death rate is higher. With
competition for space being a pivotal tumor-inhibiting factor, the
introduction of a 10-fold higher spontaneous death rate α in CCs
results in accelerated tumor growth and host tissue invasion, along
with a more rapid increase in CSC number and percentage within
the tumor (Figure 6).
DISCUSSION
The existence of a minor subpopulation of CSCs within a
tumor that drives tumor initiation, growth, and progression is
an attractive hypothesis to explain primary tumor dynamics and
transplantation experiments. The existence of a minor fraction
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FIGURE 5 | Representative simulations of tumor growth from a single
cancer stem cell and invasion of adjacent muscle and fat tissue. (A)
H&E staining of an LLC tumor – host tissue interface. (B) Close-up of the
marked region in (A) of the tumor outside and invading the muscle/fat
tissue. Scale bar=500µm. (C) Initial condition for the computer model.
Domain is initialized using an image mask of the muscle tissue identified in
(B). A single cancer stem cell is placed in the top right corner (arrow). (D,E)
In vivo tumor morphology is dictated by host tissue architecture regardless
of intrinsic tumor kinetics. (D) Cancer cells (purple) in a pure stem cell
tumor (ps =100%) have proliferated within the space and invaded the
muscle. The simulation snapshot correlates to the time point marked by * in
(F). (E) Same as Case (D) but for the heterogeneous tumor (ps =10%). The
simulation snapshot correlates to the time point marked by ** in (F). (F)
Number of tumor cells over time for symmetric stem cell division
probabilities ps =100% (red line) and ps =10% (blue plot). The simulation is
run until both tumors reach a comparable size of 15,000 cells. The tumor
composed purely of stem cells reaches this size after 100 days, whereas
the heterogeneous tumor (ps =10%) takes more than 72 months. In the
latter case, the area outside the muscle is completely occupied after
12 months, harboring 60 cancer stem cells (dashed blue plot). By time
72 months, the number of cancer stem cells outside the muscle has
increased to 2050. Shown are the averages and standard deviations of 10
independent simulations (G) Representative simulation snapshots of
different time points of tumor growth and invasion in a tumor with
ps =10%. The time points are marked in (F) with black vertical lines. The
space adjacent to the muscle is quickly occupied, whereas the invasion of
the muscle architecture takes a long time. Stem cells must invade to seed
new cells in the less dense tissue within and beyond the muscles, but their
invasion is inhibited by their non-stem offspring with limited proliferation
capacity. Non-stem microtumors cannot be sustained and disappear over
time (blue circles). Microtumors seeded by a stem cell manifest and
become very stemmy (green circles). The stem cell pool in the tumor
adjacent to the muscle increases steadily over time as non-stem daughter
cells die off over time (α=1%).
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FIGURE 6 | Spontaneous cell death yields a higher stem cell fraction
within the tumor and promotes tumor progression. (A) Comparison
of tumor growth curves for tumors with spontaneous cell death rates
α=1% (blue plot) and α= 10% (green plot). Other parameters ps =10%
and ρmax =10. The dashed plots show the number of cancer stem in the
tumor population adjacent to the muscle for both tumors. Shown are the
averages and standard deviations of 10 independent simulations. (B)
Snapshots of different time points of tumor growth and invasion in a
tumor with α=10%. The time points are marked in (A) with black vertical
lines. The stem cell pool in the tumor adjacent to the muscle increases
rapidly over time as non-stem daughter cells die off quickly compared to
α=1% in Figure 5G.
of CSCs in leukemia has long been appreciated (Furth and Kahn,
1937), but over the last 10 years or so, CSC-like populations have
also been reported in solid tumors of, for example, the breast,
brain, prostate, and colon (Al-Hajj et al., 2003; Singh et al., 2003;
Cammareri et al., 2008; Hurt et al., 2008). The reported frequencies
with which these cells occur in a tumor varies by many orders of
magnitude; dependent, for example, on the chosen experimental
setup and purification methods (Quintana et al., 2008; Visvader
and Lindeman, 2008). Furthermore, the size of the CSC pool can
be modulated by availability of certain host growth factors like EGF
(Lathia et al., 2011), Sonic hedgehog (Takezaki et al., 2011), Wnt
(Vermeulen et al., 2010), or Notch (Wang et al., 2009), supporting
the idea of a CSC niche (He et al., 2009; Borovski et al., 2011).
Here we present a cellular automaton model of tumor growth
and invasion of heterogeneous cancer populations comprised of
CSCs and their progeny. Simulations of the model reveal multiple
indications on the fraction of CSCs in solid tumors: (i) intrinsic
stem cell symmetric division probabilities results in tumors with
different stem cell ratios and morphologies, (ii) CSCs are intrinsi-
cally a minor subpopulation within a tumor, and (iii) the stem cell
ratio within a tumor is variable over time with intratumoral and
environmental competition for limited resources – space in the
case of muscle invasion – selecting for and thus enriching in CSC
fraction. In fact, competition such as for space and the resulting
selection for CSCs has recently been shown to yield a pure CSC
population over time (Hillen et al., 2013).
The frequency of symmetric division events in CSCs has previ-
ously been identified as a pivotal determinant of stem cell propor-
tion experimentally (Cicalese et al., 2009) as well as in a variety of
theoretical approaches including differential equations (Johnston
et al., 2010), agent-based approaches (Enderling et al., 2009a), and
hybrid models (Sottoriva et al., 2010).
CC proliferation capacity and the space- and time-dependent
evolution of the CSC fraction in solid tumors offers a novel aug-
mentation to the ongoing discussion about the frequencies at
which CSCs are observed (Pardal et al., 2003; Quintana et al.,
2008; Visvader and Lindeman, 2008). Furthermore, the CSC
fraction, as determined by host environmental factors that con-
trol the symmetric division probability, determines whether the
tumor exhibits an invasive or compact morphology, although the
relationship is non-monotonic. Intrinsic tumor growth can be
described as conglomerates of self-metastases (Enderling et al.,
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2009b, 2010), but over time a solid tumor core forms with more or
less invasive boundary clustering. While lower and higher stem
cell fractions yield more compact morphologies, intermediate
fractions result in the most invasive tumor morphologies. These
results augment findings of a monotonic increase of invasiveness
with decreased stem cell fraction (Sottoriva et al., 2010). When
additional host spatial constraints are imposed on the growing
tumor, intrinsic morphological features disappear. Conceivably,
the indistinguishable pathological morphologies that result could,
in a clinical setting based on empirical observations, lead to the
recommendation of comparable treatment protocols. However,
due to their different CSC fractions, morphologically compara-
ble tumors could in fact demonstrate response patterns rang-
ing from complete regression [for low CSC content (Enderling
et al., 2009c)] to resistance and accelerated re-growth (Gao et al.,
2013).
Herein we limited our study to early avascular tumor growth
where the total population is sufficiently small such that oxy-
gen diffusion and tension can be neglected and global tumor
growth dynamics be derived from different intrinsic CC kinetics.
Simulations of larger tumor volumes will require physiological
extension of the model to include nutrient delivery (Anderson
and Chaplain, 1998; Ribba et al., 2004; Frieboes et al., 2007;
Macklin et al., 2009) and vascular carrying capacities (Folkman,
1971; Folkman and Hochberg, 1973; Hahnfeldt et al., 1999). Fur-
thermore, a translation from the cellular level model to a tissue-
level continuous description might be more feasible to augment
our understanding of the dynamics of larger populations (Hillen
et al., 2013). For computational convenience we also limited
this study to two spatial dimensions, but emphasize that exten-
sion to three spatial dimensions is algorithmically straightforward
(Enderling et al., 2009b), with no qualitative change to be expected
in the results here reported.
However, one transcendent feature expected to survive model
simplifications is the possibility of widely varying stem cell com-
positions, highly dependent on host structural and biochemical
context. This finding needs to be taken into account in both the
clinical and research arenas, where heretofore, the threat has been
presumed to come from the tumor bulk as a whole, not from a
limited subpopulation within it.
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